VYVANSE lisdexamfetamine dimesilate 40 mg capsules bottle

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 12bec0f779a8ab24
Product Name: VYVANSE lisdexamfetamine dimesilate 40 mg capsules bottle
Artg Id: 284020
Artg Name: VYVANSE lisdexamfetamine dimesilate 40 mg capsules bottle
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2017-11-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/50426a7733213868879ae11b824ad89c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/25869bd738320b16a6e6ad7cd5257fc8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

12bec0f779a8ab24

Type

Standard